The acute graft-versus-host disease (aGvHD) market involves drugs that are used to prevent the onset of aGvHD in patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT). aGvHD occurs when the donated (graft) immune cells (T-cells) attack the recipient's (host) body tissues. The drugs used for preventing aGvHD work by suppressing the immune system and redu... https://articlescad.com/software-rental-service-an-innovative-business-model-emerges-335621.html